Importance of duodenogastric reflux in gastro-oesophageal reflux disease

British Journal of Surgery

Volumn 93, Issue 12, 2006, Pages 1475-1482

  Fein, M ^a   Maroske, J ^a   Fuchs, K H ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b AGAPLESION MARKUS KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADOLESCENT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DUODENOGASTRIC REFLUX; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ABSORPTION; SUPINE POSITION;

ADOLESCENT; ADULT; AGED; BILE; BILIRUBIN; DUODENOGASTRIC REFLUX; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 33845446366     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5486     Document Type: Article

References (35)

1. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl 2): S1-S16.
2. Pellegrini CA, DeMeester TR, Wernly JA, Johnson LF, Skinner DB. Alkaline gastroesophageal reflux. Am J Surg 1978; 135: 177-184.
3. Kauer WK, Peters JH, DeMeester TR, Feussner H, Ireland AP, Stein HJ et al. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 1997; 122: 874-881.
4. Nehra D, Howell P, Pye JK, Beynon J. Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease. Br J Surg 1998; 85: 134-137.
5. Bechi P, Pucciani F, Baldini F, Cosi F, Falciai R, Mazzanti R et al. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993; 38: 1297-1306.
6. Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994; 267: G1050-G1057.
7. Stipa F, Stein HJ, Feussner H, Kraemer S, Siewert JR. Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus 1997; 10: 24-28.
8. Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994; 107: 747-754.
9. Caldwell MTP, Lawlor P, Byrne PJ, Walsh TN, Hennessy TPJ. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1995; 82: 657-660.
10. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525-531.
11. Tack J, Koek G, Demedts I, Sifrim D, Janssens J. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barren's esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004; 99: 981-988.
12. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995; 108: 1897-1907.
13. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117: 699-704.
14. Fein M, Ireland AP, Ritter MP, Peters JH, Hagen JA, Bremner CG et al. Duodenogastric reflux potentiates the injurious effects of gastroesophageal reflux. J Gastrointest Surg 1997; 1: 27-33.
15. Stein HJ, Kauer WK, Feussner H, Siewert JR. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998; 2: 333-341.
16. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, Miyazaki I et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996; 67: 269-274.
17. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002; 122: 1101-1112.
18. Nishijima K, Miwa K, Miyashita T, Kinami S, Ninomiya I, Fushida S et al. Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 2004; 240: 57-67.
19. Theisen J, Peters JH, Fein M, Hughes M, Hagen JA, DeMeester SR et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg 2005; 241: 63-68.
20. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000; 231: 303-321.
21. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000; 356: 2079-2085.
22. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-1031.
23. Müller-Lissner SA, Fimmel CJ, Sonnenberg A, Will N, Muller-Duysing W, Heinzel F et al. Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut 1983; 24: 510-518.
24. Fiorucci S, Distrutti E, Di Matteo F, Brunori P, Santucci L, Mallozzi E et al. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol 1995; 90: 270-276.
25. Koek GH, Vos R, Sifrim D, Cuomo R, Janssens J, Tack J. Mechanisms underlying duodeno-gastric reflux in man. Neurogastroenterol Motil 2005; 17: 191-199.
26. Romagnoli R, Collard JM, Bechi P, Salizzoni M. Gastric symptoms and duodenogastric reflux in patients referred for gastroesophageal reflux symptoms and endoscopic esophagitis. Surgery 1999; 125: 480-486.
27. Byrne JP, Romagnoli R, Bechi P, Attwood SE, Fuchs KH, Collard JM. Duodenogastric reflux of bile in health: the normal range. Physiol Meas 1999; 20: 149-158.
28. Fein M, Freys SM, Sailer M, Maroske J, Tigges H, Fuchs KH. Gastric bilirubin monitoring to assess duodenogastric reflux. Dig Dis Sci 2002; 47: 2769-2774.
29. Bollschweiler E, Wolfgarten E, Putz B, Gutschow C, Holscher AH. Bile reflux into the stomach and the esophagus for volunteers older than 40 years. Digestion 2005; 71: 65-71.
30. Marshall RE, Anggiansah A, Owen WA, Manifold DK, Owen WJ. The extent of duodenogastric reflux in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001; 13: 5-10.
31. Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111.
32. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-1199.
33. Barrett MW, Myers JC, Watson DI, Jamieson GG. Dietary interference with the use of Bilitec to assess bile reflux. Dis Esophagus 1999; 12: 60-64.
34. Bremner CG. Inseparable sphincters. Interrelationship between the pyloric and the lower oesophageal sphincters. S Afr J Surg 1989; 27: 119-124.
35. Stein HJ, Barlow AP, DeMeester TR, Hinder RA. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992; 216: 35-43.